Clinical Trials in Pittsburgh

Showing 7741-7760 of 21,047 trials

Echocardiogram and Cardiac Performance System (CPS) Ejection Fraction Validation Study

NCT05104307

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Heart Diseases

Stephen Esper79 participantsStarted Nov 2021

Pittsburgh, Pennsylvania, United States

TERMINATEDPhase 1< 1 mile

A Study of DeTIL-0255 in Adults With Advanced Malignancies

NCT05107739

This is a first-in-human Phase 1 multicenter, open-label oncology study designed to evaluate the safety and efficacy of NX-DeTIL-0255-201 in patients with advanced malignancies.

Platinum-resistant Ovarian CancerEndometrial CancerCervical Cancer

Nurix Therapeutics, Inc.5 participantsStarted Dec 2021

New Brunswick, New Jersey, United States • Buffalo, New York, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.

NCT01928576

Response Rate

Non-Small Cell Lung CancerEpigenetic Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins143 participantsStarted Nov 2013

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States +2 more locations

Echocardiogram and Cardiac Performance System (CPS) Ejection Fraction Validation Study

A Study of DeTIL-0255 in Adults With Advanced Malignancies

Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.

Find Trials by Condition in Pittsburgh

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Hypofractionated SBRT For Prostate Cancer

Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)

MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)

CYCLE: A Randomized Clinical Trial of Early In-bed Cycling for Mechanically Ventilated Patients

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)

Financial Incentives for Smoking Treatment II

Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist

Optimizing Functional Recovery of Breast Cancer Survivors